PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
Lisa BodeiMark S KiddAviral SinghWouter A van der ZwanStefano SeveriIgnat A DrozdovAnna MalczewskaRichard P BaumDik J KwekkeboomGiovanni PaganelliEric P KrenningIrvin M ModlinPublished in: European journal of nuclear medicine and molecular imaging (2019)
PPQ predicts PRRT response in 97%. NETest accurately monitors PRRT response and is an effective surrogate marker of PRRT radiological response. NETest decrease identified responders and correlated (> 97%) with the pretreatment PPQ response predictor. CgA was non-informative.
Keyphrases